It is strongly suggestive that modulating mortalin levels either chemically (natural and synthetic) or genetically in AD can prevent beta-amyloid–mediated damage and might reduce the neuronal loss and neurocognitive dysfunction. Here, HSPA9 is linked to Alzheimer disease.